Immix Biopharma, Inc.

Immix Biopharma, Inc.verified

IMMX

Price:

$2.31

Market Cap:

$63.54M

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorpor...[Read more]

Industry

Biotechnology

IPO Date

2021-12-16

Stock Exchange

NASDAQ

Ticker

IMMX

The Enterprise Value as of December 2024 (TTM) for Immix Biopharma, Inc. (IMMX) is 44.94M

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.94M. This represents a change of -19.73% compared to the average of 55.99M of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical Enterprise Value (quarterly & annually)

How has IMMX Enterprise Value performed in the past?

The mean historical Enterprise Value of Immix Biopharma, Inc. over the last ten years is 39.37M. The current 44.94M Enterprise Value has changed 11.32% with respect to the historical average. Over the past ten years (40 quarters), IMMX's Enterprise Value was at its highest in in the December 2023 quarter at 120.35M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

39.37M

Median

29.50M

Minimum

15.75M

Maximum

102.49M

Immix Biopharma, Inc. (IMMX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 508.00%

Maximum Annual Enterprise Value = 102.49M

Minimum Annual Increase = -42.86%

Minimum Annual Enterprise Value = 15.75M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023102.49M508.00%
202216.86M-42.86%
202129.50M-8.50%
202032.24M104.66%

Immix Biopharma, Inc. (IMMX) Average Enterprise Value

How has IMMX Enterprise Value performed in the past?

The current Enterprise Value of Immix Biopharma, Inc. (IMMX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

49.62M

5-year avg

39.37M

10-year avg

39.37M

Immix Biopharma, Inc. (IMMX) Enterprise Value vs. Peers

How is IMMX’s Enterprise Value compared to its peers?

Immix Biopharma, Inc.’s Enterprise Value is greater than ZyVersa Therapeutics, Inc. (2.27M), greater than Hepion Pharmaceuticals, Inc. (5.10M), greater than AVROBIO, Inc. (-85302404.00), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than CNS Pharmaceuticals, Inc. (-698881.00), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), greater than Sonnet BioTherapeutics Holdings, Inc. (-1712074.00), less than Freeline Therapeutics Holdings plc (0), greater than Enveric Biosciences, Inc. (2.82M), greater than CohBar, Inc. (176.25K), greater than Elevation Oncology, Inc. (-4519416.00), greater than Ocean Biomedical, Inc. (16.98M), greater than null (36.77M),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Immix Biopharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Immix Biopharma, Inc. (IMMX)?

What is the 3-year average Enterprise Value for Immix Biopharma, Inc. (IMMX)?

What is the 5-year average Enterprise Value for Immix Biopharma, Inc. (IMMX)?

How does the current Enterprise Value for Immix Biopharma, Inc. (IMMX) compare to its historical average?